Alpha-1 antitrypsin (AAT), an endogenous serine protease inhibitor for neutrophil elastase (NE), is emerging as a novel immunomodulatory agent to intervene immune diseases and transplantation (12). This evidence concerns the gene ELANE and immune system disorder.